Comparison of effects of nebivolol, carvedilol and irbesartan on left ventricular hypertrophy associated with hypertension

DEĞİRMENCİ, HÜSNÜ; AÇIKEL, Mahmut; BAKIRCI, EFTAL; DUMAN, HAKAN; DEMİRELLİ, SELAMİ; TAŞ, Muhammed; ŞİMŞEK, Ziya; KARAKELLEOĞLU, Şule; AKSAKAL, Erdi; Erol, M.

Comparison of effects of nebivolol, carvedilol and irbesartan on left ventricular hypertrophy associated with hypertension

DEĞİRMENCİ H., AÇIKEL M., BAKIRCI E. M., DUMAN H., DEMİRELLİ S., TAŞ M. H., ...Daha Fazla

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.18, sa.5, ss.630-637, 2014 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 5
Basım Tarihi: 2014
Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.630-637
Anahtar Kelimeler: New generation beta-blockers, Irbesartan, Left ventricular hypertrophy, PROGNOSTIC IMPLICATIONS, MASS, REGRESSION, ATENOLOL, HEART
Atatürk Üniversitesi Adresli: Evet

Özet

OBJECTIVES: The aim of this study was to investigate if the new generation beta-blockers are as effective as irbesartan, which is an angiotensin receptor blocker (ARB), on left ventricular hypertrophy (LVH).